Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.
Nancy E. Cornish,Nancy L. Anderson,Diego G. Arambula,Matthew J. Arduino,Andrew Bryan,Nancy C. Burton,Bin Chen,Beverly A. Dickson,Judith G. Giri,Natasha K. Griffith,Michael A. Pentella,Reynolds M. Salerno,Paramjit Sandhu,James W. Snyder,Christopher A. Tormey,Elizabeth A. Wagar,Elizabeth G. Weirich,Sheldon Campbell,Nancy E Cornish,Nancy L Anderson,Diego G Arambula,Matthew J Arduino,Nancy C Burton,Beverly A Dickson,Judith G Giri,Natasha K Griffith,Michael A Pentella,Reynolds M Salerno,James W Snyder,Christopher A Tormey,Elizabeth A Wagar,Elizabeth G Weirich
DOI: https://doi.org/10.1128/cmr.00126-18
IF: 36.8
2021-06-11
Clinical Microbiology Reviews
Abstract:Patient care and public health require timely, reliable laboratory testing. However, clinical laboratory professionals rarely know whether patient specimens contain infectious agents, making ensuring biosafety while performing testing procedures challenging. The importance of biosafety in clinical laboratories was highlighted during the 2014 Ebola outbreak, where concerns about biosafety resulted in delayed diagnoses and contributed to patient deaths. This review is a collaboration between subject matter experts from large and small laboratories and the federal government to evaluate the capability of clinical laboratories to manage biosafety risks and safely test patient specimens. We discuss the complexity of clinical laboratories, including anatomic pathology, and describe how applying current biosafety guidance may be difficult as these guidelines, largely based on practices in research laboratories, do not always correspond to the unique clinical laboratory environments and their specialized equipment and processes. We retrospectively describe the biosafety gaps and opportunities for improvement in the areas of risk assessment and management; automated and manual laboratory disciplines; specimen collection, processing, and storage; test utilization; equipment and instrumentation safety; disinfection practices; personal protective equipment; waste management; laboratory personnel training and competency assessment; accreditation processes; and ethical guidance. Also addressed are the unique biosafety challenges successfully handled by a Texas community hospital clinical laboratory that performed testing for patients with Ebola without a formal biocontainment unit. The gaps in knowledge and practices identified in previous and ongoing outbreaks demonstrate the need for collaborative, comprehensive solutions to improve clinical laboratory biosafety and to better combat future emerging infectious disease outbreaks.
microbiology